tiprankstipranks
Trending News
More News >
Ecolab Inc (ECL)
NYSE:ECL
Advertisement

Ecolab (ECL) AI Stock Analysis

Compare
1,429 Followers

Top Page

ECL

Ecolab

(NYSE:ECL)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
$297.00
â–²(11.13% Upside)
Ecolab's overall stock score is driven by its strong financial performance and positive earnings call sentiment. While technical analysis and valuation suggest caution, the company's robust growth and strategic execution in key segments provide a solid foundation. The absence of significant corporate events further emphasizes the focus on financial and operational strengths.
Positive Factors
Revenue Growth
Strong revenue growth indicates Ecolab's effective market strategies and expanding customer base, enhancing its competitive position in the specialty chemicals industry.
Operational Efficiency
Sustained healthy margins reflect Ecolab's operational efficiency and ability to manage costs, supporting long-term profitability and financial stability.
Cash Generation
Solid cash generation supports Ecolab's ability to fund strategic initiatives and investments, ensuring continued growth and resilience in its operations.
Negative Factors
Commodity Cost Increases
Rising commodity costs can pressure margins and increase operational expenses, potentially impacting profitability if not managed effectively.
Challenges in Basic Industries
Uneven demand in key segments like paper and basic industries could hinder revenue growth and require strategic adjustments to maintain overall performance.
Pricing Pressure
Pricing pressure in the Water division may affect revenue and margin growth, necessitating strategic pricing adjustments to sustain profitability.

Ecolab (ECL) vs. SPDR S&P 500 ETF (SPY)

Ecolab Business Overview & Revenue Model

Company DescriptionEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
How the Company Makes MoneyEcolab generates revenue through multiple streams, primarily by offering a wide array of products and services tailored to various industries, including food and beverage, healthcare, hospitality, and manufacturing. The company's revenue model consists of direct sales of chemical products and equipment, as well as recurring revenue from service contracts and maintenance agreements. Significant partnerships with large corporations and government entities further enhance its earnings potential. Ecolab also invests in innovation and technology to develop new solutions that meet evolving customer needs, thereby driving growth through improved customer retention and expanded market reach.

Ecolab Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Breaks down sales across various business areas, indicating which segments are performing well and contributing most to overall revenue growth.
Chart InsightsEcolab's Industrial and Institutional segments show robust growth, with the Industrial segment consistently expanding and reaching new highs by the end of 2024. However, the Healthcare and Lifesciences segment faces volatility, with a notable decline in late 2024. The 'Other' and 'Corporate' segments have ceased contributing to revenue in 2025, indicating possible strategic shifts or divestitures. This restructuring could signal a focus on core growth areas, but the absence of earnings call commentary leaves potential risks and strategic intentions unclear.
Data provided by:Main Street Data

Ecolab Earnings Call Summary

Earnings Call Date:Jul 29, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 28, 2025
Earnings Call Sentiment Positive
Ecolab's earnings call reflected a generally positive sentiment, with strong earnings growth, resilient core business performance, and advancements in digital and high-tech segments. However, challenges remain in certain segments like basic industries and paper, as well as ongoing commodity cost pressures. Overall, the positives in growth and strategic execution outweighed the areas of concern.
Q2-2025 Updates
Positive Updates
Strong Earnings Growth
Ecolab reported double-digit earnings growth, achieving a 13% increase in earnings for the second quarter, in line with expectations and guidance.
Resilient Business Portfolio
85% of Ecolab's business grew organic sales by 4% and operating income by 18%, demonstrating the strength and resilience of its business portfolio.
Growth in Core Segments
Global Water sales growth accelerated to 4%, and operating income grew double digits, led by food and beverage and strong execution of the One Ecolab growth strategy.
Pest Elimination and Digital Advancements
Pest Elimination's organic sales growth accelerated to 6%, driven by the shift to a digital pest intelligence model, with operating income margins increasing to nearly 20%.
Strong Balance Sheet and Cash Flow
Ecolab maintains a strong balance sheet with a low leverage ratio of 1.7, positioning the company for organic and inorganic growth opportunities.
Life Sciences and Global High-Tech Growth
Life Sciences grew mid-single digits, with strong double-digit growth in biopharma, and Global High-Tech business sales were up over 30%.
Negative Updates
Challenges in Basic Industries and Paper Business
End market demand remained uneven, particularly in the paper and basic industries businesses, which represent 15% of Ecolab's total sales.
Commodity Cost Increases
Commodity costs are anticipated to keep increasing by low to mid-single digits in the second half of the year and in 2026.
Pricing Pressure
Pricing in the Water division was lower than expected, with a need to improve pricing in the second half, particularly in basic and paper industries.
Company Guidance
During Ecolab's second quarter 2025 earnings call, the company reported strong financial performance consistent with its guidance. It achieved a 3% growth in organic sales, driven by a robust 4% growth in 85% of its business, while operating income grew by 18%. Key growth drivers included a 2% increase in value pricing, which is anticipated to rise closer to 3% in subsequent quarters due to a new trade surcharge for U.S. customers. The Institutional & Specialty segment, along with Global Water, performed well, with the latter seeing 4% sales growth excluding paper and basic industries, which faced challenges. The Pest Elimination business showed a 6% organic sales increase, with operating income margins nearing 20%. Ecolab's growth engines, including Pest Elimination, Life Sciences, Global High-Tech, and Ecolab Digital, collectively grew double digits, contributing to a 170 basis points rise in operating income margin. Despite anticipated commodity cost increases, Ecolab expects its full-year 2025 operating income margin to reach 18%, with an aim for a 20% margin by 2027, supported by continued investment in high-margin growth businesses.

Ecolab Financial Statement Overview

Summary
Ecolab demonstrates strong financial performance with consistent revenue growth and robust profitability margins. The balance sheet reflects a stable capital structure with manageable leverage, while the cash flow position underscores efficient cash generation capabilities. Potential risks include the high debt level, but the company's growth trajectory and profitability trends are promising.
Income Statement
85
Very Positive
Ecolab's income statement reflects strong profitability with a consistent increase in gross profit margin from 41.4% in 2020 to 43.7% in TTM 2025. The net profit margin has also improved, reaching 13.4% in TTM 2025, indicating efficient cost management. Revenue growth has been steady, with a notable 21.0% increase from 2020 to 2021 and continued growth across subsequent years, though slightly declining in TTM 2025. EBIT and EBITDA margins have shown robust performance, reflecting operational efficiency. Overall, Ecolab demonstrates solid revenue growth and profitability metrics.
Balance Sheet
78
Positive
Ecolab's balance sheet shows a stable financial position with a debt-to-equity ratio of 0.93 in TTM 2025, highlighting moderate leverage. The return on equity has improved from 15.9% in 2020 to 23.7% in TTM 2025, indicating effective use of shareholder equity. The equity ratio remains reasonable at 39.7%, suggesting a balanced capital structure. However, the company's total debt level, while stable, remains significant, which could pose a risk in adverse economic conditions.
Cash Flow
80
Positive
Ecolab's cash flow statement reveals a healthy free cash flow generation, with a growth rate of 27.5% from 2022 to TTM 2025. The operating cash flow to net income ratio is strong at 1.03 in TTM 2025, indicating solid cash generation relative to net income. However, the decline in free cash flow from 2024 to TTM 2025 suggests potential volatility in cash flow despite overall positive performance. The company maintains a focus on capital investments, supporting future growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue15.72B15.74B15.32B14.19B12.73B11.79B
Gross Profit6.91B6.84B6.18B5.42B5.22B4.90B
EBITDA3.95B3.85B3.03B2.55B2.47B2.22B
Net Income2.14B2.11B1.37B1.09B1.13B-1.21B
Balance Sheet
Total Assets23.74B22.39B21.85B21.46B21.21B18.13B
Cash, Cash Equivalents and Short-Term Investments1.92B1.26B919.50M598.60M359.90M1.26B
Total Debt8.97B8.28B8.73B9.03B9.16B7.11B
Total Liabilities14.39B13.60B13.77B14.21B13.95B11.92B
Stockholders Equity9.32B8.76B8.04B7.24B7.22B6.17B
Cash Flow
Free Cash Flow1.57B1.82B1.64B1.08B1.42B1.37B
Operating Cash Flow2.62B2.81B2.41B1.79B2.06B1.86B
Investing Cash Flow-436.80M-433.80M-990.50M-716.80M-4.58B-414.50M
Financing Cash Flow-632.70M-2.02B-1.05B-837.30M1.60B-341.80M

Ecolab Technical Analysis

Technical Analysis Sentiment
Positive
Last Price267.25
Price Trends
50DMA
271.52
Negative
100DMA
267.09
Positive
200DMA
256.64
Positive
Market Momentum
MACD
-2.12
Positive
RSI
44.19
Neutral
STOCH
28.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ECL, the sentiment is Positive. The current price of 267.25 is below the 20-day moving average (MA) of 270.24, below the 50-day MA of 271.52, and above the 200-day MA of 256.64, indicating a neutral trend. The MACD of -2.12 indicates Positive momentum. The RSI at 44.19 is Neutral, neither overbought nor oversold. The STOCH value of 28.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ECL.

Ecolab Risk Analysis

Ecolab disclosed 23 risk factors in its most recent earnings report. Ecolab reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ecolab Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
24.23B37.309.29%0.96%2.47%63.68%
72
Outperform
$75.75B35.7224.26%0.97%0.57%25.50%
71
Outperform
15.18B22.1123.87%1.76%0.51%17.21%
66
Neutral
60.60B39.149.98%2.68%-0.38%-39.53%
63
Neutral
23.81B18.7013.34%2.65%-10.59%-7.79%
61
Neutral
31.74B-159.74-0.84%2.16%4.55%-130.25%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ECL
Ecolab
267.25
15.21
6.03%
APD
Air Products and Chemicals
265.78
-27.30
-9.31%
PPG
PPG Industries
103.92
-27.44
-20.89%
RPM
RPM International
116.14
-4.67
-3.87%
STE
Steris
244.19
7.56
3.19%
DD
DuPont de Nemours
74.55
-13.14
-14.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 26, 2025